HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1.

Abstract
Ubiquitin-like containing PHD and Ring finger 1 (UHRF1) contributes to silencing of tumor suppressor genes by recruiting DNA methyltransferase 1 (DNMT1) to their hemi-methylated promoters. Conversely, demethylation of these promoters has been ascribed to the natural anti-cancer drug, epigallocatechin-3-gallate (EGCG). The aim of the present study was to investigate whether the UHRF1/DNMT1 pair is an important target of EGCG action. Here, we show that EGCG down-regulates UHRF1 and DNMT1 expression in Jurkat cells, with subsequent up-regulation of p73 and p16(INK4A) genes. The down-regulation of UHRF1 is dependent upon the generation of reactive oxygen species by EGCG. Up-regulation of p16(INK4A) is strongly correlated with decreased promoter binding by UHRF1. UHRF1 over-expression counteracted EGCG-induced G1-arrested cells, apoptosis, and up-regulation of p16(INK4A) and p73. Mutants of the Set and Ring Associated (SRA) domain of UHRF1 were unable to down-regulate p16(INK4A) and p73, either in the presence or absence of EGCG. Our results show that down-regulation of UHRF1 is upstream to many cellular events, including G1 cell arrest, up-regulation of tumor suppressor genes and apoptosis.
AuthorsMayada Achour, Marc Mousli, Mahmoud Alhosin, Abdulkhaleg Ibrahim, Jean Peluso, Christian D Muller, Valérie B Schini-Kerth, Ali Hamiche, Sirano Dhe-Paganon, Christian Bronner
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 430 Issue 1 Pg. 208-12 (Jan 04 2013) ISSN: 1090-2104 [Electronic] United States
PMID23201574 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • CCAAT-Enhancer-Binding Proteins
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA-Binding Proteins
  • Nuclear Proteins
  • Reactive Oxygen Species
  • TP73 protein, human
  • Tumor Protein p73
  • Tumor Suppressor Proteins
  • Vascular Endothelial Growth Factor A
  • Catechin
  • epigallocatechin gallate
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases
  • DNMT1 protein, human
  • UHRF1 protein, human
  • Ubiquitin-Protein Ligases
Topics
  • Apoptosis (drug effects)
  • CCAAT-Enhancer-Binding Proteins (antagonists & inhibitors, metabolism)
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Cycle (drug effects)
  • Cyclin-Dependent Kinase Inhibitor p16 (genetics)
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases (antagonists & inhibitors, metabolism)
  • DNA-Binding Proteins (genetics)
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Genes, Tumor Suppressor (drug effects)
  • Humans
  • Jurkat Cells
  • Nuclear Proteins (genetics)
  • Promoter Regions, Genetic
  • Reactive Oxygen Species (metabolism)
  • Tumor Protein p73
  • Tumor Suppressor Proteins (genetics)
  • Ubiquitin-Protein Ligases
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: